Ivan Do Rodriguez

Ivan Do Rodriguez

Auto-generated profile, based on publicly available information

Ivan Do Rodriguez

Larkin Community Hospital, South Miami, FL

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
DHDonald Hathaway
Donald Hathaway
KPKrunal Pandav
Krunal Pandav
MPMadhusudan Patel
Madhusudan Patel
ARAdrian Riva-Moscoso
Adrian Riva-Moscoso
BSBishnu Mohan Singh
Bishnu Mohan Singh
RARafael Abreu
Rafael Abreu
Hathaway D, et al. Infect Chemother. 2020 Dec;52(4):478-495. https://doi.org/10.3947/ic.2020.52.4.478

10 September 2021 in Addictive Disorders & Their Treatment
Verified
Journal Article
Closed access
NWNamrata Walia
Namrata Walia
JLJessica O. Md Lat
Jessica O. Md Lat
RTRabeet Tariq
Rabeet Tariq
STSurbhi Tyagi
Surbhi Tyagi
AQAdam M. Mbbs Qazi
Adam M. Mbbs Qazi
IRIvan Do Rodriguez
Ivan Do Rodriguez
Objectives: Stimulant medications including illegal use of Methamphetamine (MA) continues to rise in adolescents and young adults. This study aims to examine mortality trends because of the stimulant overdose in this age group (15 to 34 years). Methods: Age-adjusted mortality data, including 95% confidence intervals and standard errors, were extracted using publicly available multiple causes of death files from the United States Centers for Disease Control Wide-ranging ONline Data for Epidemiologic Research (WONDER). The data was filtered using International Classification of Disease (ICD-10) codes: F15.0 (Mental and behavioral disorders because of use of other stimulants, acute intoxication), F15.1 (Mental and behavioral disorders because of use of other stimulants, harmful use), T43.6 (Psychostimulants with abuse potential). The trends analysis for 1999 to 2019 was conducted using Joinpoint regression statistical software. Results: The mortality rate has been consistently increasing in the last decade across all races and ethnicities in adolescents and young adults. Non-Hispanic White population had the highest mortality rates (7.6 per 100,000 in 2019) compared with non-Hispanic Black (3.08 per 100,000 in 2019) and Hispanic population (3.33 per 100,000 in 2019). But the annual percent change in mortality was shown to be highest in non-Hispanic Black population (34.3% between 2009 and 2019). Conclusion: The increase in overall mortality rate because of stimulants use reflects the increase of MA use in this age group. The difference in the rate of change shows worsening racial inequality. Public health policies should be implemented to include evidence-based strategies to prevent MA misuse or overdose.